BIOCOM Partnering Conf, Feb 27-28 in La Jolla

February 27-28, 2013 | The Lodge at Torrey Pines
11480 North Torrey Pines Road
La Jolla, CA 92037 | 7:00 am – 5:00pm

More Info Registration

BIOCOM’s Third Annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives and business development professionals from leading pharmaceutical and biotech companies.

The conference will include case study presentations, individual company presentations, one-on-one meetings, and numerous networking opportunities.

Speakers:

Alain Baron, President & CEO, Director, Elcelyx
Martin Birkhofer, Vice President of Strategic Transactions Group, Bristol-Myers Squibb
Miranda Biven, Partner, Wilson Sonsini Goodrich & Rosati
Richard Brudnick, Vice President of Business Development, Biogen-Idec
Tom Bumol, Site Head at AME, Eli Lilly and Company
Dan Burgess, President & CEO,Rempex Pharmaceuticals
Iain Dukes, Vice President, External Research and Development, Amgen
Lewis Geffen, Co-Chair, VC and Emerging Companies Practice, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
George S. Golumbeski, Senior Vice President Business Development, Celgene Corporation
Corey Goodman, Partner, venBio LLC
Kurt Graves, Chairman & CEO, Intarcia Therapeutics, Inc.
Richard Heyman, President and CEO, Aragon Pharmaceuticals
David Kabakoff, Executive Partner, Sofinnova
Brian McVeigh, VP, WWBD Transactions and Investment Management, GlaxoSmithKline Pharmaceuticals
Carole Nuechterlein, Head, Roche Venture Fund
Terence G. Porter, Vice President, Search & Evaluation, Global Business Development, Takeda Pharmaceuticals
Bill Rastetter, Partner, Venrock
John C. Reed, MD, Ph.D., Professor & Donald Bren Chief Executive Chair, Former CEO, Sanford-Burnham
Melinda Richter, Founder & Chief Executive Officer, Prescience International
Tony Rosenberg, Head of Global BD & Licensing, Novartis
Michael Ross, Managing Partner, SV Life Sciences
Jim Schaeffer, Executive Director of Licensing & External Research, Merck Research Labs
Susan Schaeffer, Editor, BioCentury, The Bernstein Report on BioBusiness
Jamie Topper, General Partner, Frazier Healthcare
Gonul Velicelebi, Founder, President & CEO, CalciMedica
Mark Wiggins, SVP, Business Development, Elcelyx
Rob Wills, Vice President, Alliance Management, Johnson & Johnson
Kleanthis Xanthopoulos, President and CEO, Regulus Therapeutics
Barbara Yanni, Vice President and Chief Licensing Officer, Merck